Eric D. Strobel

Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation

Nicole C. Goodwin, Giovanni Cianchetta, Hugh A. Burgoon et al. · ACS Medicinal Chemistry Letters · 2014 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Improved Solution- and Solid-Phase Preparation of Hydroxamic Acids from Esters

Chih Y. Ho, Eric D. Strobel, Janet L. Ralbovsky et al. · The Journal of Organic Chemistry · 2005 · 65 citations

Natural Sciences, Chemistry, Solid-state Chemistry +5

Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes

Nicole C. Goodwin, Zhi‐Ming Ding, Bryce A. Harrison et al. · Journal of Medicinal Chemistry · 2017 · 65 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

(6,7-Dimethoxy-2,4-dihydroindeno[1,2-<i>c</i>]pyrazol-3-yl)phenylamines:  Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors with Broad Antiproliferative Activity against Tumor Cells

Chih Y. Ho, Donald Ludovici, Umar S. M. Maharoof et al. · Journal of Medicinal Chemistry · 2005 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice

David R. Powell, Melinda Smith, Deon Doree et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +17